EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis

Spyros Foutadakis, Dimitrios Kordias iD, Giannis Vatsellas iD, Angeliki Magklara iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25136853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Spyros Foutadakis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Resistance, Neoplasm, Single-Cell Analysis, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and co-financed by Greece and the European Union (European Regional D…, Operational Programme “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014-2020).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a particularly aggressive mammary neoplasia with a high fatality rate, mainly because of the development of resistance to administered chemotherapy, the standard treatment for this disease. In this study, we employ both bulk RNA-sequencing and single-cell RNA-sequencing (scRNA-seq) to investigate the transcriptional landscape of TNBC cells cultured in two-dimensional monolayers or three-dimensional spheroids, before and after developing resistance to the chemotherapeutic agents paclitaxel and doxorubicin. Our findings reveal significant transcriptional heterogeneity within the TNBC cell populations, with the scRNA-seq identifying rare subsets of cells that express resistance-associated genes not detected by the bulk RNA-seq. Furthermore, we observe a partial shift towards a highly mesenchymal phenotype in chemoresistant cells, suggesting the epithelial-to-mesenchymal transition (EMT) as a prevalent mechanism of resistance in subgroups of these cells. These insights highlight potential therapeutic targets, such as the PDGF signaling pathway mediating EMT, which could be exploited in this setting. Our study underscores the importance of single-cell approaches in understanding tumor heterogeneity and developing more effective, personalized treatment strategies to overcome chemoresistance in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDrug Resistance, NeoplasmSingle-Cell AnalysisEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGene Expression ProfilingHumansFemaleCell Line, TumorPaclitaxelTranscriptomeDoxorubicinAntineoplastic Agents

Stichwörter der Autor:innen

3D spheroidsbulk RNA-sequencingchemoresistancesingle-cell RNA-sequencingtranscriptomicstriple-negative breast cancer

Substanzen

PaclitaxelDoxorubicinAntineoplastic Agents

Autor:innen und Institutionen

  • Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
  • Biomedical Research Institute-Foundation for Research and Technology, 45110 Ioannina, Greece.
  • Department of Clinical Chemistry, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
  • Institute of Biosciences, University Research Center of Ioannina (URCI), 45110 Ioannina, Greece.

ORCID-Profile: Dimitrios Kordias, Giannis Vatsellas, Angeliki Magklara

Förderung

  • Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and co-financed by Greece and the European Union (European Regional D…
  • Operational Programme “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014-2020)

Zitieren

APA

Foutadakis, S., Kordias, D., Vatsellas, G., & Magklara, A. (2024). Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25136853

Vancouver

Foutadakis S, Kordias D, Vatsellas G, Magklara A. Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25136853

BibTeX
@article{Foutadakis2024,
  author = {Foutadakis, Spyros and Kordias, Dimitrios and Vatsellas, Giannis and Magklara, Angeliki},
  title = {Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25136853}
}
Kostenlos starten →